Data from Newron's study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS) | Region
MILAN--(BUSINESS WIRE)--Apr 8, 2024--
Stay updated with breaking news from Mc Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS-News: Heidelberg Pharma AG / Key word: Miscellaneous Heidelberg Pharma to host R&D Webinar following novel data presented at AACR 05.04.2024 / 09:30 CET/CEST The...
CARBIOS joins Paris Good Fashion to accelerate textile circularity and contribute to more sustainable fashion Clermont-Ferrand, France, Tuesday 26 March 2024 CARBIOS , a pioneer in the...
EQS-News: Heidelberg Pharma AG / Key word: Annual Results Heidelberg Pharma announces financial figures and reports on successful business performance in 2023 25.03.2024...
EQS-News: Heidelberg Pharma AG / Key word(s): Annual Results Heidelberg Pharma announces financial figures and reports on su...